| Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences W Rayford, AT Beksac, J Alger, M Alshalalfa, M Ahmed, I Khan, ... Communications biology 4 (1), 670, 2021 | 60 | 2021 |
| Racial and ethnic disparities in prostate cancer outcomes in the veterans affairs health care system K Yamoah, KM Lee, S Awasthi, PR Alba, C Perez, TR Anglin-Foote, ... JAMA Network Open 5 (1), e2144027-e2144027, 2022 | 59 | 2022 |
| Comparative genomics reveals distinct immune-oncologic pathways in African American men with prostate cancer S Awasthi, A Berglund, J Abraham-Miranda, RJ Rounbehler, K Kensler, ... Clinical Cancer Research 27 (1), 320-329, 2021 | 59 | 2021 |
| Macrophage-derived cholesterol contributes to therapeutic resistance in prostate cancer A El-Kenawi, W Dominguez-Viqueira, M Liu, S Awasthi, ... Cancer research 81 (21), 5477-5490, 2021 | 54 | 2021 |
| Prostate cancer racial disparities: a systematic review by the prostate cancer foundation panel BA Mahal, T Gerke, S Awasthi, HR Soule, JW Simons, A Miyahira, ... European urology oncology 5 (1), 18-29, 2022 | 48 | 2022 |
| African‐American men and prostate cancer‐specific mortality: a competing risk analysis of a large institutional cohort, 1989–2015 VL Williams, S Awasthi, AK Fink, JM Pow‐Sang, JY Park, T Gerke, ... Cancer medicine 7 (5), 2160-2171, 2018 | 38 | 2018 |
| Commercial gene expression tests for prostate cancer prognosis provide paradoxical estimates of race-specific risk JH Creed, AE Berglund, RJ Rounbehler, S Awasthi, JL Cleveland, ... Cancer Epidemiology, Biomarkers & Prevention 29 (1), 246-253, 2020 | 25 | 2020 |
| African American specific gene panel predictive of poor prostate cancer outcome MI Echevarria, S Awasthi, CH Cheng, AE Berglund, RJ Rounbehler, ... The Journal of urology 202 (2), 247-255, 2019 | 24 | 2019 |
| Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and … Z Yuan, D Fernandez, J Dhillon, J Abraham-Miranda, S Awasthi, Y Kim, ... Prostate cancer and prostatic diseases 24 (1), 140-149, 2021 | 21 | 2021 |
| Optimizing time to treatment to achieve durable biochemical disease control after surgery in prostate cancer: a multi-institutional cohort study S Awasthi, T Gerke, JY Park, FA Asamoah, VL Williams, AK Fink, ... Cancer Epidemiology, Biomarkers & Prevention 28 (3), 570-577, 2019 | 15 | 2019 |
| Contemporary radiation treatment of prostate cancer in Africa: a Ghanaian experience FA Asamoah, J Yarney, S Awasthi, V Vanderpuye, PS Venkat, AK Fink, ... Journal of Global Oncology 4, 1-13, 2018 | 15 | 2018 |
| Genomic testing in localized prostate cancer can identify subsets of African Americans with aggressive disease S Awasthi, GD Grass, J Torres-Roca, PAS Johnstone, J Pow-Sang, ... JNCI: Journal of the National Cancer Institute 114 (12), 1656-1664, 2022 | 14 | 2022 |
| Tristetraprolin is a prognostic biomarker for poor outcomes among patients with low-grade prostate cancer RJ Rounbehler, AE Berglund, T Gerke, MM Takhar, S Awasthi, W Li, ... Cancer Epidemiology, Biomarkers & Prevention 27 (11), 1376-1383, 2018 | 13 | 2018 |
| Prostate tumors of native men from West Africa show biologically distinct pathways—A comparative genomic study K Yamoah, FA Asamoah, AOD Abrahams, S Awasthi, JE Mensah, ... The Prostate 81 (16), 1402-1410, 2021 | 12 | 2021 |
| Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer AE Berglund, RJ Rounbehler, T Gerke, S Awasthi, CH Cheng, M Takhar, ... Prostate cancer and prostatic diseases 22 (2), 292-302, 2019 | 11 | 2019 |
| Variation in molecularly defined prostate tumor subtypes by self-identified race KH Kensler, S Awasthi, M Alshalalfa, BJ Trock, SJ Freedland, ... European Urology Open Science 40, 19-26, 2022 | 9 | 2022 |
| Novel transcriptomic interactions between immune content and genomic classifier predict lethal outcomes in high-grade prostate cancer K Yamoah, S Awasthi, BA Mahal, SG Zhao, GD Grass, A Berglund, ... European urology 81 (4), 325-330, 2022 | 9 | 2022 |
| KLK3 SNP–SNP interactions for prediction of prostate cancer aggressiveness HY Lin, PY Huang, CH Cheng, HY Tung, Z Fang, AE Berglund, A Chen, ... Scientific reports 11 (1), 9264, 2021 | 8 | 2021 |
| Interrelationship between health insurance status and prostate cancer grade can have critical impact on prostate cancer disease control: a retrospective cohort study S Awasthi, T Gerke, VL Williams, F Asamoah, AK Fink, R Balkrishnan, ... Cancer Control 26 (1), 1073274819837184, 2019 | 8 | 2019 |
| Augmenting cancer control efforts in a limited resource setting by leveraging international collaborations in radiation oncology J Yarney, HA Anie, V Vanderpuye, FA Asamoah, B Awuah, C Edusa, ... Appl Rad Oncol 8 (2), 22-26, 2019 | 6 | 2019 |
Kosj YamoahMoffitt Cancer Center & Research Institute, University of South FloridaBestätigte E-Mail-Adresse bei moffitt.org
